Glenmark Pharmaceuticals Ltd

BSE Code : 532296
NSE Symbol : GLENMARK
ISIN : INE935A01035
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

1,830.40 46.90(2.63%)

Open Price (₹)

1,778.10

Prev. Close (₹)

1,783.50

Volume (No’s)

814,811

Market Cap (₹)

51,654.04

Low Price (₹)

1,775.00

High Price (₹)

1,843.30

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Profit and Loss

	Mar 2024 (₹.Cr)	Mar 2023 (₹.Cr)	Mar 2022 (₹.Cr)	Mar 2021 (₹.Cr)	Mar 2020 (₹.Cr)	Mar 2019 (₹.Cr)
INCOME :
Sales Turnover	7,891.12	8,220.66	8,141.58	7,567.93	6,712.63	6,304.87
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	7,891.12	8,220.66	8,141.58	7,567.93	6,712.63	6,304.87
Other Income	6,238.36	985.94	1,044.96	470.13	625.34	954.61
Stock Adjustments	103.07	31.37	16.13	-5.24	-48.77	-471.81
Total Income	14,232.55	9,237.97	9,202.67	8,032.82	7,289.20	6,787.67
EXPENDITURE :
Raw Materials	3,313.19	3,427.07	3,474.66	2,944.53	2,617.22	1,887.15
Power & Fuel Cost	104.92	95.09	91.34	80.49	90.76	82.99
Employee Cost	1,434.78	1,346.51	1,193.20	1,107.40	1,072.33	969.98
Other Manufacturing Expenses	375.32	304.66	297.44	267.26	230.03	218.75
Selling & Administrative Expenses	1,199.17	1,246.10	1,062.89	914.37	977.77	992.83
Miscellaneous Expenses	325.15	855.71	349.97	358.30	371.53	353.89
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	6,752.52	7,275.13	6,469.50	5,672.35	5,359.63	4,505.58
Operating Profit	7,480.02	1,962.84	2,733.18	2,360.47	1,929.57	2,282.08
Interest	277.11	206.82	236.04	265.90	256.39	223.81
Gross Profit	7,202.91	1,756.02	2,497.14	2,094.57	1,673.18	2,058.27
Depreciation	202.16	184.15	159.70	150.82	138.54	106.28
Profit Before Tax	7,000.75	1,571.87	2,337.44	1,943.75	1,534.64	1,951.99
Tax	1,049.99	386.93	411.08	343.62	269.24	383.50
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	783.46	-23.83	-71.42	-49.31	-89.14	-53.61
Reported Net Profit	5,167.29	1,208.77	1,997.79	1,649.45	1,354.55	1,622.11
Extraordinary Items	3,742.26	-369.56	354.02	59.87	14.43	277.16
Adjusted Net Profit	1,425.03	1,578.33	1,643.77	1,589.58	1,340.12	1,344.95
Adjustment below Net Profit	-4.76	0.63	1.61	2.48	-5.42	-3.54
P & L Balance brought forward	16,002.82	14,863.96	12,921.86	11,340.47	10,059.38	8,508.84
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	77.22	70.54	57.30	70.54	68.03	68.03
P & L Balance carried down	21,088.13	16,002.82	14,863.96	12,921.86	11,340.47	10,059.38
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	250.00	250.00	250.00	250.00	250.00	200.00
Dividend Per Share(Rs)	2.50	2.50	2.50	2.50	2.50	2.00
Earnings Per Share-Unit Curr	183.11	42.84	70.80	58.46	48.00	57.49
Earnings Per Share(Adj)-Unit Curr	183.11	42.84	70.80	58.46	48.00	57.49
Book Value-Unit Curr	814.01	633.57	593.21	524.84	468.73	423.22
Book Value(Adj)-Unit Curr	814.01	633.57	593.21	524.84	468.73	423.22